4//SEC Filing
LIKEN JAMES W 4
Accession 0001235802-24-000079
CIK 0001253176other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 3:16 PM ET
Size
13.8 KB
Accession
0001235802-24-000079
Insider Transaction Report
Form 4
VAPOTHERM INCVAPO
LIKEN JAMES W
Director
Transactions
- Sale
Common Stock
2024-01-22$0.91/sh−17,500$15,957→ 50,308 total - Disposition to Issuer
Stock Option (right to buy)
2024-09-20−1,089→ 0 totalExercise: $18.48Exp: 2032-07-27→ Common Stock (1,089 underlying) - Disposition to Issuer
Common Stock
2024-09-20$2.18/sh−4,500$9,810→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2024-09-20−1,187→ 0 totalExercise: $150.00Exp: 2029-07-24→ Common Stock (1,187 underlying) - Disposition to Issuer
Common Stock
2024-09-20$2.18/sh−50,308$109,671→ 0 total
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.92, inclusive. The reporting person undertakes to provide to Vapotherm, Inc. (Company), any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Disposed of pursuant to an Agreement and Plan of Merger, dated as of June 17, 2024, among Veronica Holdings, LLC, Veronica Intermediate Holdings, LLC, Veronica Merger Sub, Inc. and the Company, in exchange for a cash payment of $2.18 per share.
- [F3]The restricted stock unit awards, which these shares were subject to, were canceled in the merger in exchange for a cash payment of $2.18 per underlying share.
- [F4]This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2020 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.
- [F5]This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2023 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.
Documents
Issuer
VAPOTHERM INC
CIK 0001253176
Entity typeother
Related Parties
1- filerCIK 0001186465
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 3:16 PM ET
- Size
- 13.8 KB